Meyers Pete A. 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 7, 2020
Insider Transaction Report
Form 4
Meyers Peter A.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-01-05+19,500→ 45,900 total - Tax Payment
Common Stock
2020-01-07$57.38/sh−632$36,264→ 45,268 total - Award
Employee Stock Option (right to buy)
2020-01-05+48,000→ 48,000 totalExercise: $59.80Exp: 2030-01-04→ Common Stock (48,000 underlying)
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 5, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents shares withheld to satisfy withholding tax obligations.
- [F4]The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 5, 2021, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.